Wilson disease: Clinical and biological aspects;La maladie de Wilson: Aspects clinicobiologiques

Annales de Biologie Clinique

Volumn 63, Issue 5, 2005, Pages 457-466

  Chappuis, P ^a   Bost, M ^b   Misrahi, M ^c   Duclos Vallee J C ^d   Woimant, F ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔPITAL DEBROUSSE   (France)

^c BICÊTRE HOSPITAL   (France)

^d HÔPITAL PAUL BROUSSE   (France)

Author keywords

Diagnosis; Wilson disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CATION TRANSPORT PROTEIN; CHELATING AGENT; COPPER; WILSON DISEASE PROTEIN;

CHEMISTRY; CHROMOSOME 13; CHROMOSOME MAP; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; METABOLISM; MUTATION; PEDIGREE; REVIEW; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; CATION TRANSPORT PROTEINS; CHELATING AGENTS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; MUTATION; PEDIGREE; POLYMORPHISM, GENETIC;

EID: 30744465933     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Larin D. Characterization of the interaction between the Wilson and Menkes disease proteins and the cytoplasmic copper chaperone, HAH1p. J Biol Chem 1999 ; 40 : 28497-504.
2. Lutsenko S, Tsivkovskii R, Walker JM. Functional properties of the human copper transporting ATPase ATP7B (the Wilson's disease protein) and regulation by metallochaperone atox1. Ann N Y Acad Sci 2003 ; 986 : 204-11.
3. Sokol RJ, Twedt D, McKim JM, Devreaux MW, Karrer FM, Kam I. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994 ; 107 : 1788-98.
4. Farinati F, Cardin R, D'inca R, Naccarato R, Sturniolo GC. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease. J Lab Clin Med 2003 ; 141 : 372-7.
5. Gitlin JD. Wilson disease. Gastroenterology 2003 ; 125 : 1868-77.
6. Langner C, Denk H. Wilson disease. Virchows Arch 2004 ; 445 : 111-8.
7. Ala A, Schilsky ML. Wilson disease : pathophysiology, diagnosis, treatment, and screening. Clin Liver Dis 2004 ; 8 : 787-805.
8. Schilsky ML. Wilson disease : new insights into pathogenesis, diagnosis and future therapy. Curr Gastroenterol Rep 2005 ; 7 : 26-31.
9. Martin-Duverneuil N, De Broucker T. Images, maladie de Wilson. Rev Neurol 2001 ; 157 : 119-21.
10. Patel AD, Bozdech M. Wilson disease. Arch Ophtalm 2001 ; 119 : 1556.
11. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liv Intern 2003 ; 23 : 139-42.
12. Hiyamuta S, Shimizu K, Aoki T. Early diagnosis of Wilson's disease. Lancet 1993 ; 342 : 56-7.
13. Macintyre G, Gutfreund KS, Martin WRW, Camicioli R, Cox DW. Value of an enzymatic assay for the determination of serum ceruloplasmin. J Lab Clin Med 2004 ; 144 : 294-301.
14. Arnaud J, Chappuis P, Zawislak R, et al. Comparison of serum copper determination by colorimetric and atomic absorption spectrometric methods in seven different laboratories. The SFBC (Société française de biologie clinique) Trace Element Group. Clin Biochem 1993 ; 26 : 43-9.
15. Arnaud J. Détermination du cuivre et du zinc. In : Chappuis P, ed. Technique d'analyse des oligoéléments. Paris : Lavoisier Tec-Doc, 1995 : 77-92.
16. Roberts EA, Schilsky ML. A practical guideline on Wilson disease. Hepatology 2003 ; 37 : 1475-92.
17. Brewer GJ. Diagnosis of Wilson's disease : an experience over three decades. Gut 2002 ; 50 : 136.
18. Pineau A, Guillard O, Chappuis P, Arnaud J, Zawislak R. Sampling conditions of biological fluids for monitoring trace elements at hospital : a practical review. Crit Rev Clin Lab Sci 1993 ; 30 : 203-22.
19. Pilloni L, Lecca S, Van Eyken P, et al. Value of histochemical stains for copper in the diagnosis of Wilson's disease. Histopathology 1998 ; 33 : 28-33.
20. Gollan JL, Gollan TJ. Wilson disease in 1998 : genetic, diagnostic and therapeutic aspects. J Hepatol 1998 ; 28 : 28-36.
21. Petrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH, Gilliam TC. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase : genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 1994 ; 3 : 1647-56.
22. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene : spectrum of mutations and their consequences. Nat Genet 1995 ; 9 : 210-7. Erratum in : Nat Genet 1995 ; 9 : 451.
23. Vidaud D, Assouline B, Lecoz P, Cadranel JF, Chappuis P. Misdiagnosis revealed by genetic linkage analysis in a family with Wilson disease. Neurology 1995 ; 46 : 1485-6.
24. Firneisz G, Lakatos PL, Szalay F, Polli C, Glant TT, Ferenci P. Common mutations of ATP7B in Wilson disease patients from Hungary. Am J Med Genet 2002 ; 108 : 23-8.
25. Cox DW, Roberts E. Wilson disease. http://www.geneclinics.org/profiles/ wilson/details.html.
26. Kenney S, Cox DW. Wilson Disease, http://www.uofa-medical-genetics.org/ wilson/index.php.
27. Bonne-Tamir B, Kreisberg-Zacharin R. Wilson's disease. http://life2.tau.ac.il/GeneDis/Tables/Wilson/wilson.html.
28. Stapelbroek JM, Bollen CW, Van Amstel JKP, et al. The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease : results of a meta-analysis. J Hepatol 2004 ; 41 : 758-63.
29. Becuwe C, Dalle S, Ronger-Savle S, et al. Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine. Dermatology 2005 ; 210 : 60-3.
30. Brewer GJ, Hedera P, Kluin KJ, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate : III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 2003 ; 60 : 379-85.
31. Matsumura A, Hiraishi H, Terano A. Plasma exchange for hemolytic crisis in Wilson disease. Ann Intern Med 1999 ; 131 : 866.
32. Sen S, Felldin M, Steiner C, et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease. Liver Transpl 2002 ; 8 : 962-7.
33. Morgan CT, Tsivkovskii R, Kosinsky YA, Efremov RG, Lutsenko S. The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase : analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F. J Biol Chem 2004 ; 279 : 36363-71.